Mobile and Social Media’s Impact on Compliance


As a regulated industry, many health care organizations have avoided the use of social media. Yet, as more and more consumers turn to online channels for health advice and information – 40% of consumers say that information found via social media affects the way they manage their health – providers are realizing that mobile and social media platforms actually provide an opportunity for HCPs and patients to communicate outside the office and potentially result in better treatment.
[Read more…]

Digital Transformation in Europe (Social Media) is Possible


The subject of digital transformation in Europe has been raised quite frequently over the last six months during nearly all of my conversations and meetings with pharmaceutical companies and promotional agencies.   And while there is much to be said about this topic, the short answer on what is the best way to compliantly execute digital media across the pond is that you should retain a good lawyer.
[Read more…]

FDA Social Media Guidelines in 2015: Engaging with Your Audience on Their Terms


Since the first Food and Drug Administration (FDA) hearings about Social Media in 2009, clarification on proper use and the overall comfort level surrounding the use of social channels for pharmaceutical marketing has been gradual. Now, half-way through the 2010s, marketers and the FDA are facing a new set of marketing technology challenges, driven by the explosion of mobile devices, along with an increasing reliance on responsive web design to proportion web experiences on-the-fly according to screen-size.
[Read more…]